Sales jump, net loss widens at Clearwater med tech company
Apyx Medical Corp. (Nasdaq: APYX), a Clearwater medical device and supply manufacturer, reported a net loss of $4.3 million, or 13 cents a share, on revenue of $6.6 million for the second quarter of 2019. Revenue from continuing operations was up 78 percent year over year, but the net loss widened from $2.9 million in the second quarter of 2018. Apyx now expects total revenue in the range of $26.5 million to $27.5 million for the full year of 2019, a news release said. The company said in a regulatory filing that it set aside $500,000 for defense costs in a class action lawsuit, although it believes the allegations are without merit.